NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Savoir Capital

Savoir Capital

Overview

Savoir Capital is an investment firm that focuses on early-stage innovations in the health sector, including Bio-Pharmaceuticals, New Chemical Entities, Medical Devices, Medical Technologies, Digital Health, and Diagnostics. The firm aims to support its portfolio companies by leveraging the knowledge and experience of its expert group to bring health projects to market, with a particular focus on helping projects from emerging markets succeed in highly regulated global markets.

Portfolio Companies

1

Investments

Savoir Capital investments
CompanyDateStageLead
Spiral TherapeuticsJan 2023VC RoundLead
Spiral TherapeuticsMay 2019Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

Headquarters
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.